These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 31606236)

  • 21. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
    Gong S; Jin S; Li Y; Jiang W; Zhang Z; Shen Z; Wang J; Zhou H; Liu X; Xu X; Ding X; Shi Y; Liu H
    Front Immunol; 2021; 12():769802. PubMed ID: 35003086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
    PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers for the progression of IgA nephropathy.
    Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
    J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy.
    Zhang J; Ren P; Wang Y; Feng S; Wang C; Shen X; Weng C; Lang X; Chen Z; Jiang H; Chen J
    Kidney Blood Press Res; 2017; 42(3):541-552. PubMed ID: 28922659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on predicting renal progression in IgA nephropathy.
    Barbour S; Reich H
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):214-220. PubMed ID: 29432215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
    BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
    Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary C4d and progression of kidney disease in IgA vasculitis.
    Yu G; Zhao J; Wang M; Chen Y; Feng S; Li B; Wang C; Wang Y; Jiang H; Chen J
    Nephrol Dial Transplant; 2024 Sep; 39(10):1642-1648. PubMed ID: 38373839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
    Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
    Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
    Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J; Bauer F; Fitzner C; Hilgers RD; Seibert F; Babel N; Doevelaar A; Eitner F; Floege J; Rauen T; Westhoff TH
    Kidney Blood Press Res; 2018; 43(5):1563-1572. PubMed ID: 30347407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
    Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y; Zhu L; Zhou T; Zhang Q; Shi S; Liu L; Lv J; Zhang H
    PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.